References
Aref, H. (1984). Stirring by chaotic advection. Journal of Fluid Mechanics , 143 , 1–21. https://doi.org/10.1017/S0022112084001233
Bhagat, A. A. S., Kuntaegowdanahalli, S. S., Kaval, N., Seliskar, C. J., & Papautsky, I. (2010). Inertial microfluidics for sheath-less high-throughput flow cytometry. Biomedical Microdevices ,12 (2), 187–195. https://doi.org/10.1007/s10544-009-9374-9
Bilal, M. Y., Vacaflores, A., & Houtman, J. C. (2015). Optimization of methods for the genetic modification of human T cells. Immunology and Cell Biology , 93 (10), 896–908. https://doi.org/10.1038/icb.2015.59
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015). Therapeutic genome editing: prospects and challenges. Nature Medicine , 21 (2), 121–131. https://doi.org/10.1038/nm.3793
Escoffre, J.-M., Portet, T., Wasungu, L., Teissié, J., Dean, D., & Rols, M.-P. (2009). What is (Still not) Known of the Mechanism by Which Electroporation Mediates Gene Transfer and Expression in Cells and Tissues. Molecular Biotechnology , 41 (3), 286–295. https://doi.org/10.1007/s12033-008-9121-0
Franssen, L. E., Mutis, T., Lokhorst, H. M., & van de Donk, N. W. C. J. (2019). Immunotherapy in myeloma: how far have we come?Therapeutic Advances in Hematology , 10 , 204062071882266. https://doi.org/10.1177/2040620718822660
Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., … Porteus, M. H. (2015). Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nature Biotechnology , 33 (9), 985–989. https://doi.org/10.1038/nbt.3290
Jarrell, J. A., Twite, A. A., Lau, K. H. W. J., Kashani, M. N., Lievano, A. A., Acevedo, J., … Pawell, R. S. (2019). Intracellular delivery of mRNA to human primary T cells with microfluidic vortex shedding. Scientific Reports , 9 (1), 3214. https://doi.org/10.1038/s41598-019-40147-y
Kebriaei, P., Singh, H., Huls, M. H., Figliola, M. J., Bassett, R., Olivares, S., … Cooper, L. J. N. (2016). Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells. Journal of Clinical Investigation , 126 (9), 3363–3376. https://doi.org/10.1172/JCI86721
Kyle, R. A., Gertz, M. A., Witzig, T. E., Lust, J. A., Lacy, M. Q., Dispenzieri, A., … Greipp, P. R. (2003). Review of 1027 Patients With Newly Diagnosed Multiple Myeloma. Mayo Clinic Proceedings ,78 (1), 21–33. https://doi.org/10.4065/78.1.21
Lenz, P., Bacot, S. M., Frazier-Jessen, M. R., & Feldman, G. M. (2003). Nucleoporation of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells 1.FEBS Letters , 538 (1–3), 149–154. https://doi.org/10.1016/S0014-5793(03)00169-8
Levine, B. L., Miskin, J., Wonnacott, K., & Keir, C. (2017). Global Manufacturing of CAR T Cell Therapy. Molecular Therapy - Methods & Clinical Development , 4 , 92–101. https://doi.org/10.1016/j.omtm.2016.12.006
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010). Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials , 31 (32), 8494–8506. https://doi.org/10.1016/j.biomaterials.2010.07.064
Palumbo, A., & Anderson, K. (2011). Multiple Myeloma. New England Journal of Medicine , 364 (11), 1046–1060. https://doi.org/10.1056/NEJMra1011442
Roodman, G. D. (1999). Cell biology of the osteoclast.Experimental Hematology , 27 (8), 1229–1241. https://doi.org/10.1016/S0301-472X(99)00061-2
Rosazza, C., Haberl Meglic, S., Zumbusch, A., Rols, M.-P., & Miklavcic, D. (2016). Gene Electrotransfer: A Mechanistic Perspective.Current Gene Therapy , 16 (2), 98–129. https://doi.org/10.2174/1566523216666160331130040
Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians , 66 (1), 7–30. https://doi.org/10.3322/caac.21332
Stewart, M. P., Langer, R., & Jensen, K. F. (2018). Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts.Chemical Reviews , 118 (16), 7409–7531. https://doi.org/10.1021/acs.chemrev.7b00678
Tchou, J., Zhao, Y., Levine, B. L., Zhang, P. J., Davis, M. M., Melenhorst, J. J., … June, C. H. (2017). Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer. Cancer Immunology Research ,5 (12), 1152–1161. https://doi.org/10.1158/2326-6066.CIR-17-0189
Wang, X., & Rivière, I. (2016). Clinical manufacturing of CAR T cells: foundation of a promising therapy. Molecular Therapy - Oncolytics , 3 , 16015. https://doi.org/10.1038/mto.2016.15
Whitesides, G. M. (2006). The origins and the future of microfluidics.Nature , 442 , 368.
Xia, D., Quan, P., Piao, H., Piao, H., Sun, S., Yin, Y., & Cui, F. (2010). Preparation of stable nitrendipine nanosuspensions using the precipitation–ultrasonication method for enhancement of dissolution and oral bioavailability. European Journal of Pharmaceutical Sciences , 40 (4), 325–334. https://doi.org/10.1016/j.ejps.2010.04.006
Zhang, M., Ma, Z., Selliah, N., Weiss, G., Genin, A., Finkel, T. H., & Cron, R. Q. (2014). The impact of Nucleofection® on the activation state of primary human CD4 T cells. Journal of Immunological Methods ,408 , 123–131. https://doi.org/10.1016/j.jim.2014.05.014